A Novel Proteomics-Based Clinical Diagnostics Technology Identifies Heterogeneity in Activated Signaling Pathways in Gastric Cancers

• Jeeyun Lee ,

  Contributed equally to this work with: Jeeyun Lee, Phillip Kim

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Sung Kim ,

  * E-mail: sungkimm@skku.edu (SK); wkkang@skku.edu (WK)

  Affiliation Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Phillip Kim ,

  Contributed equally to this work with: Jeeyun Lee, Phillip Kim

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Xinjun Liu,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Tani Lee,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Kyoung-Mee Kim,

  Affiliation Department of Pathology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• In-Gu Do,

  Affiliations Department of Pathology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea, Samsung Cancer Research Institute, Samsung Medical Center, Seoul, Korea

  ⨯
• Joon Oh Park,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Se Hoon Park,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Jiryeon Jang,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Nicholas Hoe,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Gulia Harvie,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Anne Kuller,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Anjali Jain,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Gary Meyer,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Glen Leesman,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
• Young Suk Park,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Min Gew Choi,

  Affiliation Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Tae Sung Sohn,

  Affiliation Department of Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Jae Moon Bae,

  Affiliation Department of Pathology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Ho Yeong Lim,

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• Sharat Singh,

  Affiliation Research and Development, Oncology, Prometheus Laboratories, San Diego, California, United States of America

  ⨯
•  [ ... ],
• Won Ki Kang

  * E-mail: sungkimm@skku.edu (SK); wkkang@skku.edu (WK)

  Affiliation Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul, Korea

  ⨯
• [ view all ]
• [ view less ]